ss-lup-332 FAQ

Ship lyophilized peptide on dry ice in insulated packaging with temperature monitoring. Never ship reconstituted peptide unless absolutely unavoidable. Lyophilized SS-LUP-332 tolerates shipping at -20°C for 48–72 hours without degradation, but once reconstituted, the peptide must remain at 2–8°C continuously, which standard cold packs cannot reliably maintain beyond 24 hours. If you must ship reconstituted peptide, use a validated pharmaceutical shipper with real-time temperature logging and next-day delivery. Any excursion above 8°C compromises peptide integrity, and there's no visual indicator to confirm whether denaturation occurred.

Verify three variables before concluding the peptide is inactive: dosage accuracy, administration timing, and exercise protocol intensity. The Saint Louis University studies that established SS-LUP-332's 70% endurance improvement used standardized treadmill protocols at 60–70% VO2max. Running to exhaustion at moderate intensity, not maximal sprints. If your protocol uses high-intensity interval training or maximal effort testing, the metabolic pathway being tested differs fundamentally, and SS-LUP-332's effects may not manifest the same way. Additionally, confirm your reconstitution followed proper bacteriostatic water ratios and that the peptide was stored refrigerated immediately after mixing.

Subcutaneous administration is viable but requires dose adjustment and monitoring for injection-site reactions. Published SS-LUP-332 research used intraperitoneal injection because it provides rapid systemic distribution with minimal tissue irritation, but subcutaneous delivery. Common in clinical settings. Can achieve similar plasma concentrations if dose timing accounts for slower absorption kinetics. Expect a 20–30 minute delay to peak plasma concentration compared to intraperitoneal administration, and monitor injection sites for redness, swelling, or nodule formation, which occasionally occur with concentrated peptide solutions. If injection-site reactions appear, dilute the peptide further or switch to intraperitoneal delivery.

Do not use it. Contact the supplier immediately. SS-LUP-332 is synthesized and shipped as lyophilized powder specifically because peptides in liquid form degrade rapidly without specialized stabilizers, and even with stabilizers, pre-mixed peptides have significantly shorter shelf lives than lyophilized forms. A clear liquid peptide arriving without your explicit order of a pre-mixed format suggests either a shipping error, contamination during packaging, or exposure to heat that caused premature reconstitution. Real Peptides ships SS-LUP-332 as sterile lyophilized powder in sealed vials under cold-chain conditions to ensure the peptide reaches your lab in its most stable form.

Explain that opening the container will compromise temperature control for a research biological material and offer to open it in a private screening area where you can immediately re-ice the container. Most officers will accept a visual inspection through the container's transparent lid or an exterior swab test without requiring full disassembly. If forced to open it, do so quickly, minimize air exchange, and replace gel packs or activate backup cooling immediately. Document the time the container was open. If it exceeds 10 minutes, the peptide may have experienced a measurable temperature spike.

Tarmac delays are the highest-risk event for peptide transport because cabin ventilation is reduced and temperatures can climb rapidly. If your passive cooling system was rated for 24 hours and you're three hours into a delay, you likely still have margin. But verify with your temperature logger after landing. Active cooling systems (USB refrigerators) should continue running off battery power during ground delays. If the delay exceeds your cooling system's rated duration, inform the lead flight attendant that you're transporting temperature-sensitive research material and request permission to access the aircraft's refrigeration (galleys have units maintaining 2–8°C for food service). This is a reasonable accommodation under ADA medical necessity provisions, though not guaranteed.

Without documentation, TSA officers have discretion to refuse passage of unlabeled vials or research materials. Your options: (1) Have your PI or lab manager email a scanned copy of the letter, display it on your phone, and request the officer accept the digital version. Some will, many won't. (2) If you have your institutional ID and the peptide has a labeled vial with a pharmacy or supplier name, explain it's for research use and provide contact information for your lab. The officer may allow passage with supervisor approval. (3) If all else fails, you may need to ship the peptide via FedEx Cold Chain or similar service and continue your travel without it. Never lie about the contents or claim it's a personal medication when it's a research compound. Misrepresentation is a federal offense and will result in confiscation and potential criminal referral.

Verify three factors before adjusting dose: substrate purity (request HPLC verification from your supplier), reconstitution pH (test with pH strips. Target 6.5–7.5), and administration timing relative to fasting windows. SLU-PP-332 requires 10–14 days of consistent dosing before mitochondrial density changes become measurable via citrate synthase activity assays or respirometry. If all three factors check out and no response occurs by day 21, increase to 35mg and reassess at day 35.

Unreconstituted lyophilized powder tolerates ambient temperature (≤25°C) for up to 7 days without significant degradation. Pack in an insulated container with ice packs if ambient temperature exceeds 25°C. Once reconstituted, use an insulin cooler rated for 2–8°C maintenance. Models like the FRIO wallet use evaporative cooling and work without electricity for 36–48 hours. Do not freeze reconstituted peptide. Ice crystal formation ruptures peptide structure irreversibly.

Accept reduced AMPK activation (approximately 25–30% lower than fasted-state dosing) and increase sample size to compensate for higher variance. Fed-state glycogen stores blunt the ATP:AMP ratio shift that primes AMPK sensitivity. You can partially offset this by extending the dosing period from 4 weeks to 6 weeks, allowing cumulative transcriptional effects to compound despite suboptimal per-dose activation.

Discard it and prepare a fresh vial. Peptide stability at 20–25°C drops to 68% potency after 14 days, but degradation accelerates non-linearly. 48 hours at ambient temperature causes 8–12% potency loss, and you cannot visually detect this degradation. Using partially degraded compound introduces data variance that undermines reproducibility. The cost of one wasted vial is negligible compared to the cost of invalidated research timelines.